Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620527 · ClinicalTrials.gov registry record
Concordance Between ctDNA Assay and FoundationOne
A clinical trial of Cancer and Neoplasms, sponsored by Foundation Medicine.
- Completed
- Registry status
- 1,400
- Enrollment target
- 1
- Study location
NCT02620527 is a study of Cancer and Neoplasms that has completed, run by Foundation Medicine. The registered enrollment target is 1,400 participants, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02620527, a study of Cancer and Neoplasms, has completed, sponsored by Foundation Medicine.
- COMPLETED
- Registry status
- 1,400 participants
- Enrollment target
- 1
- Study location
Study Summary
Foundation Medicine Inc. (FMI) is interested in studying the concordance of genomic alterations between primary and/or metastatic surgical biopsies, and circulating tumor DNA (ctDNA) within different solid tumor types and has been developing an assay in order to do so.
Conditions Studied
Study Locations (1)
Massachusetts
- Foundation Medicine - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620527
The ClinicalTrials.gov registry entry for NCT02620527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (60% lower). The listed sponsor is Foundation Medicine, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02620527 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02620527 about?
NCT02620527 is a clinical study titled "Concordance Between ctDNA Assay and FoundationOne". Foundation Medicine Inc. (FMI) is interested in studying the concordance of genomic alterations between primary and/or metastatic surgical biopsies, and circulating tumor DNA (ctDNA) within different solid tumor types and has been developing an assay in order to do so.
What is the current status of trial NCT02620527?
This trial is currently completed. The enrollment target is 1,400 participants. The study started on 2014-11. Estimated completion is 2017-12.
What conditions does trial NCT02620527 study?
This clinical trial studies the following conditions: Cancer, Neoplasms, Circulating Tumor DNA, Genomic Testing, Genomic Alterations.
Who is sponsoring clinical trial NCT02620527?
This trial is sponsored by Foundation Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02620527 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.